COMPLAINT ABOUT THE DEFAMATORY PUBLICATION MADE AGAINST OPTIVA CAPITAL PARTNERS LIMITED BY NIDCOM

Re: COMPLAINT ABOUT THE DEFAMATORY PUBLICATION MADE AGAINST OPTIVA
CAPITAL PARTNERS LIMITED BY NIDCOM

By Olushola Okunlade

The attention of the management of the Nigerians in Diaspora Commission (NiDCOM) has been drawn to another publication sponsored in the Media by Optiva Capital Partners, which was termed as, “defamatory publication by NiDCOM on 23rd January 2024, published via its verified official “X” handle (@nidcom_gov).

Optiva Capital Partners Limited through the law firm of Babalakin & Co., asking for an apology and retraction of the press statement issued on Wednesday, January 23, 2024, as contained in a letter addressed to the Chairman/CEO of NiDCOM by the law firm of Babalakin & Co., signed by Oyetola Oshobi (SAN), on behalf of Optiva Capital Partners, titled, “Complaint About the Defamatory Publication Made Against Optiva Capital Partners Limited by NiDCOM.”

NiDCOM management views this latest Media and legal threat as an attempt to be clever by half when the same Optiva Capital Partners Limited through its Managing Director/CEO, Dr. Jane Kimemia wrote the Chairman/CEO of NiDCOM, Hon. Abike Dabiri-Erewa (OON) on January 24, 2024 admitting that they had not properly followed laid down procedure  in their earlier rushed announcement while also sending emissaries to NiDCOM seeking for
partnership and understanding of its proposed Diaspora Investor Direct Investment (DIDI) product which it admitted, is still in the planning stage.

The letter sent by Optiva Capital Partners on January 24 2024 to NiDCOM speaks on “Introduction to Optiva Capital Partners and the Diaspora Investor Direct Investment (DIDI) Initiative”.

NiDCOM in its statement welcomed Optiva Capital Partners’ letter and reiterated that its responsibility at NiDCOM, is to ensure it protects the interests of hardworking and committed Nigerians abroad, willing to invest at home and will not bow to any form of threat, blackmail, and intimidation.

LEAVE A REPLY

Please enter your comment!
Please enter your name here